Fresenius Medical Care Corporation (FMS)
Fresenius Medical Care Corporation (NYSE: FMS) is a depositary receipt representing common stock of Fresenius Medical Care AG, a healthcare company focused on dialysis and related services for people with renal disease. Through its Care Delivery and Care Enablement segments, the company provides dialysis treatment, laboratory and diagnostic services, patient support, and hospital-based dialysis services in the United States for patients with end-stage renal disease or acute kidney failure. It also develops, manufactures, and distributes kidney care products such as hemodialysis machines, peritoneal dialysis systems and solutions, bloodlines, renal pharmaceuticals, and water-treatment systems. The company serves customers in Germany, the United States, and other international markets, with products and services sold through clinics, hospitals, distributors, and direct sales channels. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-FMS
|
$33.22
|
34.5% Upside
|
Undervalued
|
$25.68
|
4.0% Upside
|
Fair
|
Great
|
—
|
—
|
0.61
|
2.5%
|
August 4, 2026
|
12.2x
|
0.9x
|
0.6x
|
12.824 B
|
24.915 B
|
47.5%
|
68.4%
|
7.9
|
44.7%
|
189.0%
|